PDB Entry - 6P5M
(Status - Released)Summary information:
Title: Discovery of a Novel, Highly Potent, and Selective Thieno[3,2-d]pyrimidinone-Based Cdc7 inhibitor with a Quinuclidine Moiety (TAK-931) as an Orally Active Investigational Anti-Tumor Agent
PDB DOI: https://doi.org/10.2210/pdb6p5m/pdb
Primary publication DOI: https://doi.org/10.1021/acs.jmedchem.9b01427
Entry authors: Hoffman, I.D., Skene, R.J.
Initial deposition on: 30 May 2019
Initial release on: 15 January 2020
Latest revision on: 11 October 2023
Downloads:
Structure coordinates (PDBx/mmCIF)
Structure coordinates (PDBML)
Structure coordinates (PDB)
X-ray diffraction data (PDBx/mmCIF)
Validation report (XML)
Validation report (mmCIF)
Validation report (PDF)
Links to more resources for 6P5M at: